ZNF540 and head and neck squamous cell carcinoma: For the verification of the possible usage of ZNF540 expression level as a prognostic marker, we divided HNSCC patients into the following subgroups: all patients (HPV(+) and HPV(−)), only HPV(−), and only HPV(+).